SIDE-BY-SIDE COMPARISON

CompareEyenukvsAEYE Health

Review features, pricing signals, strengths, and trade-offs before choosing.

Generated from current catalog profiles Catalog profile signals Use-case comparison
AI Ophthalmology & Retinal Imaging Software

Eyenuk

SF 7.9

AI retinal screening across multiple eye diseases

Contact sales

Quick decision guide

Choose based on your workflow

Not enough differentiated product data yet to make a strong automatic pick.

Overview

How each tool is described

Eyenuk

Eyenuk is an AI retinal-screening platform for primary care and organized screening programs, detecting diabetic retinopathy, diabetic macular edema, and related retinal conditions.

  1. Clinical role: It supports autonomous retinal screening and care routing rather than replacing ophthalmologists, so specialist follow-up remains essential after positive results.
  2. Best-fit environment: Diabetic and multi-disease screening programs fit best where primary care sites have established referral pathways and compatible imaging hardware.
  3. Evaluation priorities: Buyers should confirm regulatory clearance, camera compatibility, validation depth, referral integration, reporting, and support before broader rollout.
  4. Commercial model: Pricing is sales-led and scoped per buyer rather than published, making implementation requirements important purchasing considerations.

Eyenuk is best evaluated as a screening layer whose value depends on workflow placement, specialist follow-up, and coordinated deployment across participating sites.

View full Eyenuk profile

AEYE Health

AEYE Health is an AI retinal diagnostics platform for primary care, providing autonomous and assistive analysis for diabetic retinopathy screening.

  1. Clinical role: It supports retinal screening and care routing rather than ophthalmologist replacement, so specialist follow-up remains essential for every positive screen surfaced through the workflow.
  2. Best-fit setting: Primary care programs may value its lightweight deployment model when adding diabetic retinopathy screening closer to routine clinical care.
  3. Implementation checks: Buyers should confirm regulatory clearance, camera and imaging hardware compatibility, downstream referral integration, reporting requirements, and review processes before rollout.
  4. Commercial model: Pricing is sales-led and scoped per buyer rather than posted publicly, making implementation scope an important purchasing consideration.

A focused pilot can clarify workflow fit, hardware compatibility, referral processes, and deployment requirements before wider primary care adoption.

View full AEYE Health profile

Side-by-side

Key differences

Criteria
AI Ophthalmology & Retinal Imaging SoftwareEyenuk
AI Ophthalmology & Retinal Imaging SoftwareAEYE Health
Best for
AI Ophthalmology & Retinal Imaging Software
AI Ophthalmology & Retinal Imaging Software
Score
7.9/10
7.8/10
Pricing
Contact sales
Contact sales
Category / audience
AI Healthcare & Medical Software › AI Ophthalmology & Retinal Imaging Software
AI Healthcare & Medical Software › AI Ophthalmology & Retinal Imaging Software

OVERLAP

Where Eyenuk and AEYE Health are similar

Both tools cover similar catalog signals. The deciding factor is usually workflow fit, implementation needs, and ecosystem fit.

4 capabilities6 workflows

Shared capabilities

Capability overlap

  • Primary Care UseDesigned for primary care screening settings
  • Care RoutingRoutes positive screens to ophthalmology
  • Retinal ScreeningScreens retinal images for disease indicators
  • Autonomous DetectionDetects diabetic retinopathy autonomously during screening

Shared workflows

Workflow overlap

  • Standardize diabetic eye screening programsStandardize diabetic eye screening across health systems.
  • Generate patient-facing screening reportsGenerate patient-facing reports from completed screenings.
  • Screen for diabetic retinopathy at scaleScreen for diabetic retinopathy across primary care sites.

Feature check

Side-by-side feature check

Feature
Eyenuk
AEYE Health
Patient ReportsGenerates patient-facing screening reports
-
Image QualityChecks captured image quality before analysis
-
Multi DiseaseCoverage across multiple retinal conditions
-
Workflow IntegrationConnects with eye care imaging workflows
-
Primary Care UseDesigned for primary care screening settings
Care RoutingRoutes positive screens to ophthalmology
8 capabilities compared.4 differentiating rows are shown first.

The trade-offs

Pros & cons of each tool

Trade-offs

Eyenuk

Pros
  • Multi-disease retinal screening focus in practice today
  • Established eye screening AI brand
  • Active programs across screening sites
Cons
  • Workflow placement remains clinic-specific
  • Positive screens require ophthalmology follow-up
  • Buyer scope is narrower than imaging giants
Trade-offs

AEYE Health

Pros
  • Lightweight deployment suits primary care screening workflows
  • Focused on diabetic retinopathy screening
  • Practical fit within clinic workflows
Cons
  • Narrower buyer scope than imaging giants
  • Specialist follow-up remains essential for now
  • Pricing requires direct sales scoping

Final verdict

Best fit depends on your workflow

Catalog verdict · low confidence

Current catalog data shows meaningful overlap between Eyenuk and AEYE Health. Use the signals below to decide based on workflow, ecosystem, pricing, and implementation fit.

Shared catalog overlap

Eyenuk and AEYE Health share 10 catalog signals, so the decision should focus on fit rather than broad capability alone.

Differentiators available

Eyenuk has 3 visible decision signals and AEYE Health has 3.

Score signal

Eyenuk has the higher SoftFinders Score in the current catalog data.

TRY THEM YOURSELF

See which one fits your workflow

Both tools have their strengths, the best way to decide is to spend a few minutes inside each.